Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiviral Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)

NCT05178173 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT05178173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05178173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiviral Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Not applicable
Overall status
Completed
Start date
January 20, 2022
Completion date
July 12, 2023
Enrollment
230 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, covid-19, sars cov 2 infection